Small-diameter vascular graft engineered using human embryonic stem cell-derived mesenchymal cells

Tissue Engineering - Part A

Volumn 20, Issue 3-4, 2014, Pages 740-750

  Sundaram, Sumati ^a,b   Echter, Andreana ^a   Sivarapatna, Amogh ^a   Qiu, Caihong ^b   Niklason, Laura ^a,b  

^a Yale University   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOREACTORS; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; GRAFTS; PROTEINS;

BIOREACTOR SYSTEM; HISTOLOGICAL ANALYSIS; HUMAN EMBRYONIC STEM CELLS; MESENCHYMAL CELLS; SMALL-DIAMETER VASCULAR GRAFTS; SMOOTH MUSCLE CELLS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CONSTRUCT;

CELLS;

ACTIN; CALPONIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOREACTOR; BLOOD VESSEL GRAFT; BLOOD VESSEL WALL; BONE TISSUE; CARTILAGE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; EMBRYONIC STEM CELL; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING;

ANIMALS; BIOREACTORS; BLOOD VESSEL PROSTHESIS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; MICROFILAMENT PROTEINS; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; RATS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84894151134     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0738     Document Type: Article

References (42)

1. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., Berry, J.D., Borden, W.B., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125, e2, 2012.
2. Syedain, Z.H., Meier, L.A., Bjork, J.W., Lee, A., and Tranquillo, R.T. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Bioma-terials 32, 714, 2011.
3. Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R., et al. Functional arteries grown in vitro. Science 284, 489, 1999.
4. L'Heureux, N., Mcallister, T.N., and la Fuente de, L.M. Tissue-engineered blood vessel for adult arterial revascu-larization. N Engl J Med 357, 1451, 2007.
5. Dahl, S.L.M., Kypson, A.P., Lawson, J.H., Blum, J.L., Strader, J.T., Li, Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 3, 68ra9, 2011.
6. Gong, Z., and Niklason, L.E. Use of human mesenchymal stem cells as alternative source of smooth muscle cells in vessel engineering. Methods Mol Biol 698, 279, 2011.
7. Wang, C., Cen, L., Yin, S., Liu, Q., Liu, W., Cao, Y., et al. A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Biomaterials 31, 621, 2010.
8. Peng, H.F., Liu, J.Y., Andreadis, S.T., and Swartz, D.D. Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media. Tissue Eng Part A 17, 981, 2011.
9. Liu, J.Y., Peng, H.F., and Andreadis, S.T. Contractile smooth muscle cells derived from hair-follicle stem cells. Cardiovasc Res 79, 24, 2008.
10. Gong, Z., and Niklason, L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22, 1635, 2008.
11. Barberi, T., Willis, L.M., Socci, N.D., and Studer, L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2, e161, 2005.
12. Vodyanik, M.A., Yu, J., Zhang, X., Tian, S., Stewart, R., Thomson, J.A., et al. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell 7, 718, 2010.
13. Olivier, E.N., Rybicki, A.C., and Bouhassira, E.E. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24, 1914, 2006.
14. Boyd, N.L., Nunes, S.S., Jokinen, J.D., Krishnan, L.N., Chen, Y., Smith, K.H., et al. Microvascular mural cell functionality of human embryonic stem cell derived mes-enchymal cells. Tissue Eng Part A 17, 1537, 2011.
15. Bajpai, V.K., Mistriotis, P., Loh, Y.-H., Daley, G.Q., and Andreadis, S.T. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res 96, 391, 2012.
16. Lian, Q., Zhang, Y., Zhang, J., Zhang, H.K., Wu, X., Zhang, Y., et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121, 1113, 2010.
17. Hwang, N.S., Varghese, S., Lee, H.J., Zhang, Z., Ye, Z., Bae, J., et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci USA 105, 20641, 2008.
18. Chen, J.L., Yin, Z., Shen, W.L., Chen, X., Heng, B.C., Zou, X.H., et al. Efficacy of hESC-MSCs in knitted silk-collagen scaffold for tendon tissue engineering and their roles. Biomaterials 31, 9438, 2010.
19. Olivier, E.N., and Bouhassira, E.E. Differentiation of human embryonic stem cells into mesenchymal stem cells by the "raclure" method. Methods Mol Biol 690, 183, 2011.
20. Niklason, L., Abbott, W., and Gao, J. Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg 33, 628, 2001.
21. Quint, C., Kondo, Y., Manson, R.J., Lawson, J.H., Dardik, A., and Niklason, L.E. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci USA 108, 9214, 2011.
22. Kurpinski, K., Lam, H., Chu, J., Wang, A., Kim, A., Tsay, E., et al. Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28, 734, 2010.
23. Tang, Y., Yang, X., Friesel, R.E., Vary, C.P.H., and Liaw, L. Mechanisms of TGF-b-induced differentiation in human vascular smooth muscle cells. J Vasc Res 48, 485, 2011.
24. Grygielko, E.T., Martin, W.M., Tweed, C., Thornton, P., Harling, J., Brooks, D.P., et al. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J Pharmacol Exp Ther 313, 943, 2005.
25. Sinha, S., Hoofnagle, M.H., Kingston, P.A., McCanna, M.E., and Owens, G.K. Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 287, C1560, 2004.
26. Kinner, B., Zaleskas, J.M., and Spector, M. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res 278, 72, 2002.
27. Boyd, N.L., Robbins, K.R., Dhara, S.K., West, F.D., and Stice, S.L. Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A 15, 1897, 2009.
28. Wang, A., Tang, Z., Li, X., Jiang, Y., Tsou, D.A., and Li, S. Derivation of smooth muscle cells with neural crest origin from human induced pluripotent stem cells. Cells Tissues Organs (Print) 195, 5, 2012.
29. Cheung, C., Bernardo, A.S., Trotter, M.W.B., Pedersen, R.A., and Sinha, S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol 30, 165, 2012.
30. Darby, I., Skalli, O., and Gabbiani, G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63, 21, 1990.
31. Sawtell, N.M., and Lessard, J.L. Cellular distribution of smooth muscle actins during mammalian embryogenesis: expression of the alpha-vascular but not the gamma-enteric isoform in differentiating striated myocytes. J Cell Biol 109(6 Pt 1), 2929, 1989.
32. Yoshida, T., and Owens, G.K. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 96, 280, 2005.
33. Gan, Q., Yoshida, T., Li, J., and Owens, G.K. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res 101, 883, 2007.
34. Pelttari, K., Winter, A., Steck, E., Goetzke, K., Hennig, T., Ochs, B.G., et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54, 3254, 2006.
35. Liu, K., Zhou, G.D., Liu, W., Zhang, W.J., Cui, L., Liu, X., et al. The dependence of in vivo stable ectopic chon-drogenesis by human mesenchymal stem cells on chondro-genic differentiation in vitro. Biomaterials 29, 2183, 2008.
36. Speer, M.Y., Yang, H.-Y., Brabb, T., Leaf, E., Look, A., Lin, W.-L., et al. Smooth muscle cells give rise to os-teochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 104, 733, 2009.
37. Lau, W.L., Pai, A., Moe, S.M., and Giachelli, C.M. Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis 18, 105, 2011.
38. Higgins, S.P., Solan, A.K., and Niklason, LE. Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. J Biomed Mater Res A 67, 295, 2003.
39. Wanjare, M., Kuo, F., and Gerecht, S. Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc Res 97, 321, 2013.
40. Lee, M., Wu, B.M., Stelzner, M., Reichardt, H.M., and Dunn, J.C.Y. Intestinal smooth muscle cell maintenance by basic fibroblast growth factor. Tissue Eng Part A 14, 1395, 2008.
41. Khan, I.M., Evans, S.L., Young, R.D., Blain, E.J., Quan-tock, A.J., Avery, N., et al. Fibroblast growth factor 2 and transforming growth factor b1 induce precocious maturation of articular cartilage. Arthritis Rheum 63, 3417, 2011.
42. Li, Q., Liu, T., Zhang, L., Liu, Y., Zhang, W., Liu, W., et al. The role of bFGF in down-regulating a-SMA expression of chondrogenically induced BMSCs and preventing the shrinkage of BMSC engineered cartilage. Biomaterials 32, 4773, 2011.